Search PubMed⌕ Search

Biomedical subjects

F Halter

Publications and source records attributed to F Halter.

At least 109 records · Page 6Linked to original sources

Effects of secretin antibody on gastric acid inhibition and pancreatic bicarbonate stimulation by acidified liver extract meal in dogs.

Duodenal acidification is known to inhibit gastric H+ secretion while stimulating pancreatic HCO-3 secretion, but the mechanisms of these effects have not been fully explained. This study was designed to determine the role of endogenous and exogenous secretin in gastric inhibition and pancreatic stimulation by an acidified liver extract (LE) meal in conscious dogs prepared with chronic gastric and pancreatic fistulas pretreated with normal serum (control) or anti-secretin serum. In control tests, plasma gastrin and gastric H+ secretion showed a marked rise with LE meals at pH ranging from 7.0 to 4.0, but significantly declined at pH 3.0 and 2.0. Plasma secretin and pancreatic secretion started to rise with LE meals at pHs below 4.5, and both reached peaks at pH 2.0. Exogenous secretin infused at graded doses suppressed plasma gastrin and gastric H+ responses to LE meals at doses of 1.0 and 2.0 U/kg-h, but increased, dose-dependently, plasma secretin and pancreatic HCO-3 starting with a dose of 0.03 U/kg-h. Following the administration of anti-secretin serum, the effects of exogenous secretin on plasma gastrin and secretin levels as well as on gastric and pancreatic secretion were almost completely abolished. The increase in plasma secretin and pancreatic HCO-3 responses to LE meals at pH below 4.5 were also abolished by anti-secretin serum, but the suppression of plasma gastrin level and the inhibition of gastric H+ responses to LE meals at lower pH (3.0 and 2.0) remained virtually unchanged.(ABSTRACT TRUNCATED AT 250 WORDS)

Animals↗

[Endoscopic insertion of endoprostheses in malignant extrahepatic bile duct stenoses].

In the vast majority of patients with malignant biliary strictures endoscopic insertion of biliary endoprostheses leads to good palliation with decline of the jaundice and disappearence of the pruritus. The prostheses are positioned immediately after diagnostic endoscopic retrograde cholangiopancreatography, thus causing only minor additional discomfort for the patients. The insertion technique is difficult, but success rates between 70 and 90% are achieved by experienced endoscopists. Complications occur in 10 to 20% and mortality is 2-3%. Thus, endoscopically inserted endoprostheses have become a good alternative to the percutaneous transhepatic procedure and in many cases even to palliative surgical biliary drainage.

Aged↗

[Psychosocial adaptation with an artificial intestinal outlet].

A total of 1625 patients with colostomy, ileostomy or urostomy, including all members of the Swiss ILCO Association, received a questionnaire concerning their medical, social, family and personal situation. 948 questionnaires were analyzed. The mean age was 64 and the time since operation 6 years. 60% regarded their postoperative instruction in stoma care as adequate, but 32% were unhappy with the preoperative information. The transstomal colonic irrigation technique was still unknown to 21% of the colostomy patients and was utilized by only 32%. One year after the operation 69% of the patients with colostomy, 83% with ileostomy and 59% with urostomy in the under-62 age group were fully reintegrated in their professions. Acceptance of the stoma by family and friends was good and there were no major difficulties in practising sports and other hobbies. Sexuality proved to be the most seriously affected aspect of their personal lives, as 33% male and 13% female patients reported major problems.

Adaptation, Psychological↗

In vitro tests overestimate in vivo neutralizing capacity of antacids in presence of food.

The neutralizing capacity of two antacids (Alucol = A, Syntrogel = S), differing both in their composition and theoretical neutralizing capacity, was evaluated in vitro and in vivo. In vitro at pH 3.5, 1 ml of A or S neutralizes 3.9 and 1.6 meq of acid, respectively, in an aqueous solution. When tested in vivo in the absence of food during near maximal acid secretion, induced by impromidine, 60 ml of either A or S reduced the 4-hr mean H+ activity by 83% and 65%, respectively. In contrast, the reduction of the 12-hr H+ activity observed after repeated administration of 30-60 ml of A or S at the end of the postprandial hour failed to reach significance with both preparations. This suggests that interaction with food produces a considerable loss of in vivo antacid neutralizing capacity, not quantitatively predictable from in vitro tests.

Adult↗

Effects of pinaverium bromide and verapamil on the motility of the rat isolated colon.

Pinaverium bromide was 30 times less potent than verapamil in inhibiting intraluminal pressure responses of in vitro rat colonic segments to barium chloride, acetylcholine, FK 33-824 or field stimulation. The inhibitory effects of both verapamil and pinaverium bromide on the pressure responses to field stimulation were antagonized similarly by exogenous calcium administration. These results support the concept that pinaverium bromide acts on calcium channels in the smooth muscle cell membrane.

Acetylcholine↗

Influence of 16,16-dimethyl prostaglandin E2 on morphology and brush border enzymes of small-bowel mucosa. Differences in reactivity between adult and suckling rats.

High doses of 16,16-dimethyl prostaglandin E2 (dmPGE) are trophic to the small bowel of adult and suckling rats. In suckling rats this effect is paralleled by an increase in brush border enzyme activities, possibly indicating accelerated mucosal maturation. To investigate the possible physiological significance of this phenomenon, we examined whether this induction of intestinal enzyme activities can be reproduced in adult rats and whether cell growth and enzyme activity might be suppressed by indomethacin. Treatment twice daily for 2 weeks with 100 micrograms/kg dmPGE by intragastric instillation increased villus length in the proximal and distal small bowel by 36% and 40%, respectively, while 2 mg/kg indomethacin by subcutaneous injection had no effect. Maltase, trehalase, lactase, and sucrase activities were unchanged after dmPGE or indomethacin. [3H]-thymidine incorporation into DNA was not significantly influenced for up to 24 h after a single dose of both 100 micrograms/kg PGE intragastrically or 10 mg/kg indomethacin subcutaneously. These studies confirm that in adult rats large doses of 16,16-dm PGE2 increase the volume of the small-bowel mucosa. In contrast to the situation in suckling rats, the activity of hydrolytic brush border enzymes is not increased. There is thus no evidence that endogenous prostaglandins are trophic or influence brush border enzymes in the adult rat.

16,16-Dimethylprostaglandin E2↗

[Modification of the growth of the gastric mucosa by drugs].

Over the last two decades it has become apparent that various drugs influence growth of gastric mucosa. For example, non-steroidal anti-inflammatory drugs increase cell shedding, which is, in rats at least, overcompensated by stimulation of cell proliferation during long-term treatment. Hyperplasia of parietal and other gastric epithelial cells has been observed in rats treated with many different ulcer drugs. Of special interest are alterations and sometimes neoplasms of gastric mucosa induced by long-term administration of very high doses of novel inhibitors of acid secretion. Some of these tumours are probably the consequence of massive hypergastrinaemia due to alkaline gastric pH and consequent lack of inhibition of gastrin release. In man the increase of gastrin is less marked even after administration of omeprazole, the most potent inhibitor of acid secretion known. Extrapolation of results from animal experiments to the situation of patients with ulcer disease is therefore questionable. However, it cannot be ruled out that total inhibition of acid secretion for a very long period could cause proliferation of gastric endocrine cells, since such tumours occur in endogenous hypergastrinaemia in patients with pernicious anaemia or Zollinger-Ellison syndrome.

Animals↗

Cyclooxygenase inhibitors affect Met-enkephalin- and acetylcholine-stimulated motility of the isolated rat colon.

Endogenous prostaglandins have been shown to modify the contractile activity of the intestinal muscle. In this study, the effects of the cyclooxygenase inhibitors phenylbutazone, diclofenac, indomethacin, acetylsalicyclic acid (ASA) and salicyclic acid (SA) on the motility of the Met-enkephalin- (FK) and acetylcholine- (ACh) stimulated isolated rat colon were observed. Intraluminal pressure changes were measured by perfusion manometry in organ preparations maintained in a standard organ bath. FK and ACh dose-dependently increased intraluminal tonic pressure with a response of 42 +/- 0.6 arbitrary units (mean +/- S.E., n = 6) at 10(-6) M FK and of 96.8 +/- 8.6 arbitrary units at 10(-4) M ACh. Oral pretreatment with ASA (300 mg/kg b.i.d. for 3 days and 1 h before removal of the colon) suppressed the stimulatory effect of FK and significantly reduced ACh stimulation of colonic tone. A similar effect was observed when ASA alone was added to the nutrient. Phenylbutazone, diclofenac or indomethacin (10(-4)-10(-3) M) in the nutrient also significantly inhibited the effects of both stimulants. In contrast, p.o. pretreatment with SA (100 mg/kg b.i.d. for 3 days and 1 h before removal of the colon) did not affect stimulatory properties of FK and ACh. SA given with the nutrient exerted a substantial inhibition of the stimulated tone. One-hour washout was sufficient to completely abolish the inhibitory action of SA but reduced that of ASA by only 25%. The data suggest that endogenous prostaglandins and/or thromboxanes are involved in the FK- and ACh-stimulated contraction of rat colonic smooth muscles.(ABSTRACT TRUNCATED AT 250 WORDS)

Acetylcholine↗

The other option in peptic ulcer therapy.

The treatment of peptic ulcer disease has been revolutionized for both the physician and the surgeon by the development of the histamine H2-antagonists, which have become the 'gold standard' for peptic ulcer therapy. However, it has been shown that several other drugs, including antacids, can match the ulcer-healing rate obtained with histamine H2-antagonist therapy with both a high- and a low-dose regimen. An important and well-documented option is the treatment of peptic ulcer disease with sucralfate. This drug, a basic amino salt of sucrose octosulphate , acts by binding to the protein of the matrix of the ulcer crater, thus coating the ulcer against the aggressive principle of acid-pepsin and probably also by a cytoprotective effect. Sucralfate is only absorbed in minimal quantities and no metabolic interaction with other drugs is therefore likely to occur. In many studies performed on different continents it has been demonstrated that sucralfate is superior to placebo in short-term duodenal and gastric ulcer healing and that the rate of healing is similar to that obtained by cimetidine. Evidence is also accumulating that sucralfate has a place in maintenance therapy to prevent recurrence of duodenal ulcer; preliminary studies also point to benefit in the therapy of reflux oesophagitis.

Aluminum↗

Simple gastroscopy technique in the rat.

We present a simple method for gastroscopy in the anesthetized rat using an implanted gastric cannula, a standard rigid arthroscope, and a newly designed valve system. The method allows high-quality endoscopy and photo documentation, large-size biopsies, electrocoagulation and fluid collection. Repeated gastroscopy in the same animal is easy and well tolerated.

Animals↗

[CT and ERCP as a combination research method in pancreatic diseases].

The value of combined CT and ERCP for studying the pancreas has been assessed in a retrospective study. CT and ERCP used singly provided a correct diagnosis in 74 and 63% respectively; the combination of these methods increased diagnostic accuracy to 86%. ERCP is employed after CT and is indicated if the pancreas appears normal, if there is suspicion of chronic pancreatitis or neoplasia, for elucidating focal masses or if there is obstructive jaundice, without its cause being visible on CT.

Acute Disease↗

16,16-Dimethyl prostaglandin E2 stimulates growth and maturation of rat gastric and small-intestinal mucosa.

In adult rats topical application of 16,16-dm PGE2 (PGE) every 8 h for three weeks led to a dose-dependent increase of the height of the gastric and duodenal mucosa, especially pronounced in the antrum (+115% with the high dose). In the gastric corpus this resulted from an enlargement of the lamina propria and the epithelial cell mass, the latter mainly from a hyperplasia of the surface and foveolar mucous cells. In contrast, the number of parietal cells was not affected. These findings were corroborated by the observation that an increase of antral mucosal height was also induced by a similar parenteral PGE treatment regimen (dosage 25 micrograms/kg). Both longterm intragastric and intraperitoneal PGE treatment led to an increase in DNA synthesis within the mucosa of the gastric antrum and corpus by 19 to 74%. In a third study 25 or 100 micrograms/kg of PGE applied every 8 h intragastrically to 10 suckling rats from the 7th to 11th postnatal day resulted in a dose-dependent increase in the length of the villi and the disaccharidase activities (30-630%). These studies suggest that 16,16-dm PGE2 exhibits a trophic effect on both the stomach and the small bowel.

16,16-Dimethylprostaglandin E2↗

Both topical and systemic treatments with 16,16-dimethyl prostaglandin E2 are trophic to rat gastric mucosa.

As shown in a previous study, intragastric administration of 16,16-dimethyl prostaglandin E2 (PGE, 100 micrograms/kg t.i.d.) for three weeks induces growth of the gastric mucosa. The present experiments were designed to study the time course of histological changes after intragastric PGE and to test whether a similar effect could be observed after parenteral administration. Significant thickening of the corpus, but not the antral mucosa was observed after 3 days of intragastric treatment with PGE (100 micrograms/kg t.i.d.), whereas after three weeks the effect was more marked in the antrum than in the corpus. At a dose of 25 micrograms/kg t.i.d., intraperitoneal PGE increased the height of antral mucosa to a similar degree as seen after intragastric treatment. DNA synthesis as assessed by autoradiography after administration of 3H-thymidine at the end of the three week PGE treatment was increased both in the gastric corpus and antrum. Preliminary studies in suckling rats provide evidence that intragastric administration of PGE (100 micrograms/kg t.i.d.) from day 7 to 11 accelerates maturation of the gastric mucosa. It is concluded that thickening of gastric mucosa can be induced by both local and systemic administration of PGE and is due, at least in part, to increased proliferation of gastric mucosal cells.

16,16-Dimethylprostaglandin E2↗

Severe pseudomembranous and ulcerative colitis during gold therapy.

A case of severe pseudomembranous and ulcerative colitis is described in a 58-year-old patient with rheumatoid arthritis receiving sodium aurothiomalate. Watery diarrhea occurred after the fourth injection (total amount 130 mg). Several months elapsed prior to full recovery after discontinuation of gold administration.

Arthritis, Rheumatoid↗

Measurement of cholecystokinin octapeptide-induced motility of rat antrum, pylorus, and duodenum in vitro.

Motor effects of cholecystokinin octapeptide (CCK-OP) on rat antrum, pylorus, and duodenum have been studied in vitro under standard conditions. Intraluminal pressure changes were simultaneously measured at the three locations using a perfusion manometric system with a novel intraluminal pressure-sensor device. This device comprised an acrylic cast of the rat gastroduodenal tract containing the perfusion catheters that reached the surface of the cast with their outlets in the antrum, pylorus, and duodenum. A selective and sensitive intraluminal local pressure measurement was achieved with this pressure sensor due to its shape. CCK-OP increased base-line pressure in the antrum, pylorus, and duodenum; frequencies of phasic contractions in the antrum and pylorus; and amplitudes in the duodenum. The peptide also decreased contraction amplitudes in the antrum and pylorus and frequency of phasic contractions in the duodenum. It is concluded that the novel intraluminal pressure sensor is a useful tool for measuring local pressure changes in the gastroduodenal tract of the rat. In this experimental model, effects of CCK-OP on antral, pyloric, and duodenal base-line pressure are comparable with those observed in isolated muscle strips and in the intact organ of humans, dogs, and opossums. A different behavior, however, was observed in the force of antral and frequency of duodenal phasic contractions.

Animals↗

Mechanism of action of cholecystokinin octapeptide on rat antrum, pylorus, and duodenum.

The mechanism of action of cholecystokinin octapeptide (CCK-OP) on tonic and phasic contraction of antral, pyloric, and duodenal smooth muscles was studied with a novel perfusion manometric system in isolated esophagogastroduodenal preparations of the rat. CCK-OP increased baseline pressure at each site, frequencies of phasic contractions in the antrum and pylorus, and amplitudes in the duodenum. It decreased antral and pyloric amplitudes and frequency of duodenal phasic contractions. CCK-OP action on tonic contraction was tetradotoxin (TTX) susceptible and its action on phasic contractions was TTX resistant. Phentolamine, phenoxybenzamine, propranolol, catecholamine depletion of preparations by reserpine-tetrabenazine, and the block of catecholamine synthesis at different levels significantly inhibited CCK-OP-induced tonic contraction, whereas atropine had no influence. Adrenergic and cholinergic neural actions on phasic contractions altered the level of amplitudes and frequencies on which CCK-OP action occurred. It is concluded that CCK-OP action on tonic contraction of the rat gastroduodenal junction is mediated by a neural noncholinergic pathway, whereas its effect on muscles responsible for phasic contractions is a direct one.

Animals↗